Mon panier

Recombinant Monoclonal Anti-CD4 Antibody, Rabbit (4F3)

Avis des utilisateurs
Numéro de produit/spécification
Prix
Qté
HGS-S255-20ul
$125.00
HGS-S255-100ul
$360.00
ETA of in-stock products:2 business days
Total des articles Montant du produit$ 0

Détails du produit

  • Background

    Recombinant Monoclonal Anti-CD4 Antibody, Rabbit (4F3) is a CD4 primary antibody for IHC application. The CD4 antigen is involved in the recognition of MHC class II molecules and is a co-receptor for HIV. CD4 is primarily expressed in a subset of T-lymphocytes, also referred to as T helper cells, but may also be expressed by other cells in the immune system, such as monocytes, macrophages, and dendritic cells.

  • Product Specifications

    Host Species
    Rabbit
    Isotype
    Rabbit IgG, Rabbit Kappa
    Clone
    4F3
    Application
    IHC-P
    Dilution Ratio
    1: 500 - 1: 2000
    Form
    Liquid
    Clonality
    Monoclonal
    Reactivity
    Human
    Synonyms
    Leu-3
    Concentration
    0.9~1.1 mg/ml
    Specificity
    React with CD4 protein on the membrane of target cell/tissue
    Purification Tech
    Protein A
    Preservation
    PBS, BSA, Glycerol
  • Experiment Protocol

    LEICA Experiment Protocol

  • Storage

    Shipped at 4°C, Blue Ice. Store at +4°C for short term (1-2 weeks). Store at -20°C for long term.
    Avoid freeze / thaw cycle. Upon delivery aliquot. The shelf life is 30 days from the date of opening.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Les clients ont également consulté

Affichage des données

  • Sample Staining Data

     CD4 SAMPLE STAINING DATA
  •  CD4 SAMPLE STAINING DATA
  •  CD4 SAMPLE STAINING DATA

    Immunohistochemical analysis of paraffin embedded human cancer tissue labelled with HGS-S255 at 1/1000 dilution.
    Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Avis des utilisateurs
Publier un commentaire

Progrès de frontière

 
Progrès du développement médicamenteux
  • Nom anglais:

    T-cell surface antigen CD4

  • Catégorie:

  • Nombre de médicaments répertoriés:

    1 Détails

  • Nombre de médicaments cliniques:

    25 Détails

  • Étape de développement la plus élevée:

    Approved

Drug Candidate Licensing
More
  • Informations de base sur le produit
  • Détails du produit
  • Les clients ont également consulté
  • Affichage des données
  • Avis des utilisateurs